Report Overview
Microbiome CDMO (Contract Development and Manufacturing Organization) is an organization that specializes in providing customized manufacturing and development services to biotechnology and pharmaceutical companies. They mainly focus on providing microbiome research with the entire process from samples to commercial products, including microbiome isolation, culture, identification, storage, extraction, preparation and related product development.
The global Microbiome CDMO market size was estimated at USD 1225 million in 2023 and is projected to reach USD 2841.56 million by 2032, exhibiting a CAGR of 9.80% during the forecast period.
North America Microbiome CDMO market size was estimated at USD 375.08 million in 2023, at a CAGR of 8.40% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Microbiome CDMO market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Microbiome CDMO Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Microbiome CDMO market in any manner.
Global Microbiome CDMO Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Arranta Bio
Wacker Chemie AG
Bactera
SGS Quay Pharma
Biose
EnteroBiotix
Genome And Company
Lallemand Health Solutions
List Bio
Rise BioServices
Lonza
MaaT Pharma
NIZO
Quay Pharmaceuticals
Recipharm
Market Segmentation (by Type)
Microbial CDMO
Antibiotic CDMO
Phage CDMO
Bacteriocins CDMO
Market Segmentation (by Application)
Vaccine R&D
Biopharmaceutical
Cell Therapy
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Microbiome CDMO Market
Overview of the regional outlook of the Microbiome CDMO Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Microbiome CDMO
1.2 Key Market Segments
1.2.1 Microbiome CDMO Segment by Type
1.2.2 Microbiome CDMO Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Microbiome CDMO Market Overview
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Microbiome CDMO Market Competitive Landscape
3.1 Global Microbiome CDMO Revenue Market Share by Company (2019-2025)
3.2 Microbiome CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Microbiome CDMO Market Size Sites, Area Served, Product Type
3.4 Microbiome CDMO Market Competitive Situation and Trends
3.4.1 Microbiome CDMO Market Concentration Rate
3.4.2 Global 5 and 10 Largest Microbiome CDMO Players Market Share by Revenue
3.4.3 Mergers & Acquisitions, Expansion
4 Microbiome CDMO Value Chain Analysis
4.1 Microbiome CDMO Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 The Development and Dynamics of Microbiome CDMO Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 Mergers & Acquisitions
5.5.2 Expansions
5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies
6 Microbiome CDMO Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Microbiome CDMO Market Size Market Share by Type (2019-2025)
6.3 Global Microbiome CDMO Market Size Growth Rate by Type (2019-2025)
7 Microbiome CDMO Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Microbiome CDMO Market Size (M USD) by Application (2019-2025)
7.3 Global Microbiome CDMO Market Size Growth Rate by Application (2019-2025)
8 Microbiome CDMO Market Segmentation by Region
8.1 Global Microbiome CDMO Market Size by Region
8.1.1 Global Microbiome CDMO Market Size by Region
8.1.2 Global Microbiome CDMO Market Size Market Share by Region
8.2 North America
8.2.1 North America Microbiome CDMO Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Microbiome CDMO Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Microbiome CDMO Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Microbiome CDMO Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Microbiome CDMO Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Arranta Bio
9.1.1 Arranta Bio Microbiome CDMO Basic Information
9.1.2 Arranta Bio Microbiome CDMO Product Overview
9.1.3 Arranta Bio Microbiome CDMO Product Market Performance
9.1.4 Arranta Bio Microbiome CDMO SWOT Analysis
9.1.5 Arranta Bio Business Overview
9.1.6 Arranta Bio Recent Developments
9.2 Wacker Chemie AG
9.2.1 Wacker Chemie AG Microbiome CDMO Basic Information
9.2.2 Wacker Chemie AG Microbiome CDMO Product Overview
9.2.3 Wacker Chemie AG Microbiome CDMO Product Market Performance
9.2.4 Wacker Chemie AG Microbiome CDMO SWOT Analysis
9.2.5 Wacker Chemie AG Business Overview
9.2.6 Wacker Chemie AG Recent Developments
9.3 Bactera
9.3.1 Bactera Microbiome CDMO Basic Information
9.3.2 Bactera Microbiome CDMO Product Overview
9.3.3 Bactera Microbiome CDMO Product Market Performance
9.3.4 Bactera Microbiome CDMO SWOT Analysis
9.3.5 Bactera Business Overview
9.3.6 Bactera Recent Developments
9.4 SGS Quay Pharma
9.4.1 SGS Quay Pharma Microbiome CDMO Basic Information
9.4.2 SGS Quay Pharma Microbiome CDMO Product Overview
9.4.3 SGS Quay Pharma Microbiome CDMO Product Market Performance
9.4.4 SGS Quay Pharma Business Overview
9.4.5 SGS Quay Pharma Recent Developments
9.5 Biose
9.5.1 Biose Microbiome CDMO Basic Information
9.5.2 Biose Microbiome CDMO Product Overview
9.5.3 Biose Microbiome CDMO Product Market Performance
9.5.4 Biose Business Overview
9.5.5 Biose Recent Developments
9.6 EnteroBiotix
9.6.1 EnteroBiotix Microbiome CDMO Basic Information
9.6.2 EnteroBiotix Microbiome CDMO Product Overview
9.6.3 EnteroBiotix Microbiome CDMO Product Market Performance
9.6.4 EnteroBiotix Business Overview
9.6.5 EnteroBiotix Recent Developments
9.7 Genome And Company
9.7.1 Genome And Company Microbiome CDMO Basic Information
9.7.2 Genome And Company Microbiome CDMO Product Overview
9.7.3 Genome And Company Microbiome CDMO Product Market Performance
9.7.4 Genome And Company Business Overview
9.7.5 Genome And Company Recent Developments
9.8 Lallemand Health Solutions
9.8.1 Lallemand Health Solutions Microbiome CDMO Basic Information
9.8.2 Lallemand Health Solutions Microbiome CDMO Product Overview
9.8.3 Lallemand Health Solutions Microbiome CDMO Product Market Performance
9.8.4 Lallemand Health Solutions Business Overview
9.8.5 Lallemand Health Solutions Recent Developments
9.9 List Bio
9.9.1 List Bio Microbiome CDMO Basic Information
9.9.2 List Bio Microbiome CDMO Product Overview
9.9.3 List Bio Microbiome CDMO Product Market Performance
9.9.4 List Bio Business Overview
9.9.5 List Bio Recent Developments
9.10 Rise BioServices
9.10.1 Rise BioServices Microbiome CDMO Basic Information
9.10.2 Rise BioServices Microbiome CDMO Product Overview
9.10.3 Rise BioServices Microbiome CDMO Product Market Performance
9.10.4 Rise BioServices Business Overview
9.10.5 Rise BioServices Recent Developments
9.11 Lonza
9.11.1 Lonza Microbiome CDMO Basic Information
9.11.2 Lonza Microbiome CDMO Product Overview
9.11.3 Lonza Microbiome CDMO Product Market Performance
9.11.4 Lonza Business Overview
9.11.5 Lonza Recent Developments
9.12 MaaT Pharma
9.12.1 MaaT Pharma Microbiome CDMO Basic Information
9.12.2 MaaT Pharma Microbiome CDMO Product Overview
9.12.3 MaaT Pharma Microbiome CDMO Product Market Performance
9.12.4 MaaT Pharma Business Overview
9.12.5 MaaT Pharma Recent Developments
9.13 NIZO
9.13.1 NIZO Microbiome CDMO Basic Information
9.13.2 NIZO Microbiome CDMO Product Overview
9.13.3 NIZO Microbiome CDMO Product Market Performance
9.13.4 NIZO Business Overview
9.13.5 NIZO Recent Developments
9.14 Quay Pharmaceuticals
9.14.1 Quay Pharmaceuticals Microbiome CDMO Basic Information
9.14.2 Quay Pharmaceuticals Microbiome CDMO Product Overview
9.14.3 Quay Pharmaceuticals Microbiome CDMO Product Market Performance
9.14.4 Quay Pharmaceuticals Business Overview
9.14.5 Quay Pharmaceuticals Recent Developments
9.15 Recipharm
9.15.1 Recipharm Microbiome CDMO Basic Information
9.15.2 Recipharm Microbiome CDMO Product Overview
9.15.3 Recipharm Microbiome CDMO Product Market Performance
9.15.4 Recipharm Business Overview
9.15.5 Recipharm Recent Developments
10 Microbiome CDMO Regional Market Forecast
10.1 Global Microbiome CDMO Market Size Forecast
10.2 Global Microbiome CDMO Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Microbiome CDMO Market Size Forecast by Country
10.2.3 Asia Pacific Microbiome CDMO Market Size Forecast by Region
10.2.4 South America Microbiome CDMO Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Microbiome CDMO by Country
11 Forecast Market by Type and by Application (2025-2032)
11.1 Global Microbiome CDMO Market Forecast by Type (2025-2032)
11.2 Global Microbiome CDMO Market Forecast by Application (2025-2032)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Microbiome CDMO Market Size Comparison by Region (M USD)
Table 5. Global Microbiome CDMO Revenue (M USD) by Company (2019-2025)
Table 6. Global Microbiome CDMO Revenue Share by Company (2019-2025)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microbiome CDMO as of 2022)
Table 8. Company Microbiome CDMO Market Size Sites and Area Served
Table 9. Company Microbiome CDMO Product Type
Table 10. Global Microbiome CDMO Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Value Chain Map of Microbiome CDMO
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Microbiome CDMO Market Challenges
Table 18. Global Microbiome CDMO Market Size by Type (M USD)
Table 19. Global Microbiome CDMO Market Size (M USD) by Type (2019-2025)
Table 20. Global Microbiome CDMO Market Size Share by Type (2019-2025)
Table 21. Global Microbiome CDMO Market Size Growth Rate by Type (2019-2025)
Table 22. Global Microbiome CDMO Market Size by Application
Table 23. Global Microbiome CDMO Market Size by Application (2019-2025) & (M USD)
Table 24. Global Microbiome CDMO Market Share by Application (2019-2025)
Table 25. Global Microbiome CDMO Market Size Growth Rate by Application (2019-2025)
Table 26. Global Microbiome CDMO Market Size by Region (2019-2025) & (M USD)
Table 27. Global Microbiome CDMO Market Size Market Share by Region (2019-2025)
Table 28. North America Microbiome CDMO Market Size by Country (2019-2025) & (M USD)
Table 29. Europe Microbiome CDMO Market Size by Country (2019-2025) & (M USD)
Table 30. Asia Pacific Microbiome CDMO Market Size by Region (2019-2025) & (M USD)
Table 31. South America Microbiome CDMO Market Size by Country (2019-2025) & (M USD)
Table 32. Middle East and Africa Microbiome CDMO Market Size by Region (2019-2025) & (M USD)
Table 33. Arranta Bio Microbiome CDMO Basic Information
Table 34. Arranta Bio Microbiome CDMO Product Overview
Table 35. Arranta Bio Microbiome CDMO Revenue (M USD) and Gross Margin (2019-2025)
Table 36. Arranta Bio Microbiome CDMO SWOT Analysis
Table 37. Arranta Bio Business Overview
Table 38. Arranta Bio Recent Developments
Table 39. Wacker Chemie AG Microbiome CDMO Basic Information
Table 40. Wacker Chemie AG Microbiome CDMO Product Overview
Table 41. Wacker Chemie AG Microbiome CDMO Revenue (M USD) and Gross Margin (2019-2025)
Table 42. Wacker Chemie AG Microbiome CDMO SWOT Analysis
Table 43. Wacker Chemie AG Business Overview
Table 44. Wacker Chemie AG Recent Developments
Table 45. Bactera Microbiome CDMO Basic Information
Table 46. Bactera Microbiome CDMO Product Overview
Table 47. Bactera Microbiome CDMO Revenue (M USD) and Gross Margin (2019-2025)
Table 48. Bactera Microbiome CDMO SWOT Analysis
Table 49. Bactera Business Overview
Table 50. Bactera Recent Developments
Table 51. SGS Quay Pharma Microbiome CDMO Basic Information
Table 52. SGS Quay Pharma Microbiome CDMO Product Overview
Table 53. SGS Quay Pharma Microbiome CDMO Revenue (M USD) and Gross Margin (2019-2025)
Table 54. SGS Quay Pharma Business Overview
Table 55. SGS Quay Pharma Recent Developments
Table 56. Biose Microbiome CDMO Basic Information
Table 57. Biose Microbiome CDMO Product Overview
Table 58. Biose Microbiome CDMO Revenue (M USD) and Gross Margin (2019-2025)
Table 59. Biose Business Overview
Table 60. Biose Recent Developments
Table 61. EnteroBiotix Microbiome CDMO Basic Information
Table 62. EnteroBiotix Microbiome CDMO Product Overview
Table 63. EnteroBiotix Microbiome CDMO Revenue (M USD) and Gross Margin (2019-2025)
Table 64. EnteroBiotix Business Overview
Table 65. EnteroBiotix Recent Developments
Table 66. Genome And Company Microbiome CDMO Basic Information
Table 67. Genome And Company Microbiome CDMO Product Overview
Table 68. Genome And Company Microbiome CDMO Revenue (M USD) and Gross Margin (2019-2025)
Table 69. Genome And Company Business Overview
Table 70. Genome And Company Recent Developments
Table 71. Lallemand Health Solutions Microbiome CDMO Basic Information
Table 72. Lallemand Health Solutions Microbiome CDMO Product Overview
Table 73. Lallemand Health Solutions Microbiome CDMO Revenue (M USD) and Gross Margin (2019-2025)
Table 74. Lallemand Health Solutions Business Overview
Table 75. Lallemand Health Solutions Recent Developments
Table 76. List Bio Microbiome CDMO Basic Information
Table 77. List Bio Microbiome CDMO Product Overview
Table 78. List Bio Microbiome CDMO Revenue (M USD) and Gross Margin (2019-2025)
Table 79. List Bio Business Overview
Table 80. List Bio Recent Developments
Table 81. Rise BioServices Microbiome CDMO Basic Information
Table 82. Rise BioServices Microbiome CDMO Product Overview
Table 83. Rise BioServices Microbiome CDMO Revenue (M USD) and Gross Margin (2019-2025)
Table 84. Rise BioServices Business Overview
Table 85. Rise BioServices Recent Developments
Table 86. Lonza Microbiome CDMO Basic Information
Table 87. Lonza Microbiome CDMO Product Overview
Table 88. Lonza Microbiome CDMO Revenue (M USD) and Gross Margin (2019-2025)
Table 89. Lonza Business Overview
Table 90. Lonza Recent Developments
Table 91. MaaT Pharma Microbiome CDMO Basic Information
Table 92. MaaT Pharma Microbiome CDMO Product Overview
Table 93. MaaT Pharma Microbiome CDMO Revenue (M USD) and Gross Margin (2019-2025)
Table 94. MaaT Pharma Business Overview
Table 95. MaaT Pharma Recent Developments
Table 96. NIZO Microbiome CDMO Basic Information
Table 97. NIZO Microbiome CDMO Product Overview
Table 98. NIZO Microbiome CDMO Revenue (M USD) and Gross Margin (2019-2025)
Table 99. NIZO Business Overview
Table 100. NIZO Recent Developments
Table 101. Quay Pharmaceuticals Microbiome CDMO Basic Information
Table 102. Quay Pharmaceuticals Microbiome CDMO Product Overview
Table 103. Quay Pharmaceuticals Microbiome CDMO Revenue (M USD) and Gross Margin (2019-2025)
Table 104. Quay Pharmaceuticals Business Overview
Table 105. Quay Pharmaceuticals Recent Developments
Table 106. Recipharm Microbiome CDMO Basic Information
Table 107. Recipharm Microbiome CDMO Product Overview
Table 108. Recipharm Microbiome CDMO Revenue (M USD) and Gross Margin (2019-2025)
Table 109. Recipharm Business Overview
Table 110. Recipharm Recent Developments
Table 111. Global Microbiome CDMO Market Size Forecast by Region (2025-2032) & (M USD)
Table 112. North America Microbiome CDMO Market Size Forecast by Country (2025-2032) & (M USD)
Table 113. Europe Microbiome CDMO Market Size Forecast by Country (2025-2032) & (M USD)
Table 114. Asia Pacific Microbiome CDMO Market Size Forecast by Region (2025-2032) & (M USD)
Table 115. South America Microbiome CDMO Market Size Forecast by Country (2025-2032) & (M USD)
Table 116. Middle East and Africa Microbiome CDMO Market Size Forecast by Country (2025-2032) & (M USD)
Table 117. Global Microbiome CDMO Market Size Forecast by Type (2025-2032) & (M USD)
Table 118. Global Microbiome CDMO Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Industrial Chain of Microbiome CDMO
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Microbiome CDMO Market Size (M USD), 2019-2032
Figure 5. Global Microbiome CDMO Market Size (M USD) (2019-2032)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Microbiome CDMO Market Size by Country (M USD)
Figure 10. Global Microbiome CDMO Revenue Share by Company in 2023
Figure 11. Microbiome CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 12. The Global 5 and 10 Largest Players: Market Share by Microbiome CDMO Revenue in 2023
Figure 13. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 14. Global Microbiome CDMO Market Share by Type
Figure 15. Market Size Share of Microbiome CDMO by Type (2019-2025)
Figure 16. Market Size Market Share of Microbiome CDMO by Type in 2022
Figure 17. Global Microbiome CDMO Market Size Growth Rate by Type (2019-2025)
Figure 18. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 19. Global Microbiome CDMO Market Share by Application
Figure 20. Global Microbiome CDMO Market Share by Application (2019-2025)
Figure 21. Global Microbiome CDMO Market Share by Application in 2022
Figure 22. Global Microbiome CDMO Market Size Growth Rate by Application (2019-2025)
Figure 23. Global Microbiome CDMO Market Size Market Share by Region (2019-2025)
Figure 24. North America Microbiome CDMO Market Size and Growth Rate (2019-2025) & (M USD)
Figure 25. North America Microbiome CDMO Market Size Market Share by Country in 2023
Figure 26. U.S. Microbiome CDMO Market Size and Growth Rate (2019-2025) & (M USD)
Figure 27. Canada Microbiome CDMO Market Size (M USD) and Growth Rate (2019-2025)
Figure 28. Mexico Microbiome CDMO Market Size (Units) and Growth Rate (2019-2025)
Figure 29. Europe Microbiome CDMO Market Size and Growth Rate (2019-2025) & (M USD)
Figure 30. Europe Microbiome CDMO Market Size Market Share by Country in 2023
Figure 31. Germany Microbiome CDMO Market Size and Growth Rate (2019-2025) & (M USD)
Figure 32. France Microbiome CDMO Market Size and Growth Rate (2019-2025) & (M USD)
Figure 33. U.K. Microbiome CDMO Market Size and Growth Rate (2019-2025) & (M USD)
Figure 34. Italy Microbiome CDMO Market Size and Growth Rate (2019-2025) & (M USD)
Figure 35. Russia Microbiome CDMO Market Size and Growth Rate (2019-2025) & (M USD)
Figure 36. Asia Pacific Microbiome CDMO Market Size and Growth Rate (M USD)
Figure 37. Asia Pacific Microbiome CDMO Market Size Market Share by Region in 2023
Figure 38. China Microbiome CDMO Market Size and Growth Rate (2019-2025) & (M USD)
Figure 39. Japan Microbiome CDMO Market Size and Growth Rate (2019-2025) & (M USD)
Figure 40. South Korea Microbiome CDMO Market Size and Growth Rate (2019-2025) & (M USD)
Figure 41. India Microbiome CDMO Market Size and Growth Rate (2019-2025) & (M USD)
Figure 42. Southeast Asia Microbiome CDMO Market Size and Growth Rate (2019-2025) & (M USD)
Figure 43. South America Microbiome CDMO Market Size and Growth Rate (M USD)
Figure 44. South America Microbiome CDMO Market Size Market Share by Country in 2023
Figure 45. Brazil Microbiome CDMO Market Size and Growth Rate (2019-2025) & (M USD)
Figure 46. Argentina Microbiome CDMO Market Size and Growth Rate (2019-2025) & (M USD)
Figure 47. Columbia Microbiome CDMO Market Size and Growth Rate (2019-2025) & (M USD)
Figure 48. Middle East and Africa Microbiome CDMO Market Size and Growth Rate (M USD)
Figure 49. Middle East and Africa Microbiome CDMO Market Size Market Share by Region in 2023
Figure 50. Saudi Arabia Microbiome CDMO Market Size and Growth Rate (2019-2025) & (M USD)
Figure 51. UAE Microbiome CDMO Market Size and Growth Rate (2019-2025) & (M USD)
Figure 52. Egypt Microbiome CDMO Market Size and Growth Rate (2019-2025) & (M USD)
Figure 53. Nigeria Microbiome CDMO Market Size and Growth Rate (2019-2025) & (M USD)
Figure 54. South Africa Microbiome CDMO Market Size and Growth Rate (2019-2025) & (M USD)
Figure 55. Global Microbiome CDMO Market Size Forecast by Value (2019-2032) & (M USD)
Figure 56. Global Microbiome CDMO Market Share Forecast by Type (2025-2032)
Figure 57. Global Microbiome CDMO Market Share Forecast by Application (2025-2032)
